| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/15/2009 | CA2692738A1 O-desmethylvenlafaxine |
| 01/15/2009 | CA2692610A1 Pharmaceutical preparations containing highly volatile silicones |
| 01/15/2009 | CA2692606A1 Inhalable solid amorphous particles comprising tiotropiium bromide and a co-solid |
| 01/15/2009 | CA2692546A1 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 01/15/2009 | CA2692545A1 Hydrogel polymeric compositions and methods |
| 01/15/2009 | CA2692482A1 Pharmaceutical composition for topical application of poorly soluble compounds |
| 01/15/2009 | CA2691695A1 Glp-1-fc fusion protein formulation |
| 01/15/2009 | CA2691398A1 Dermatological composition containing calcitriol lipidic vesicles, method for preparing same and use thereof |
| 01/15/2009 | CA2690773A1 Pharmaceutical liquid composition of botulinum toxin with improved stability |
| 01/15/2009 | CA2683712A1 Pharmaceutical compositions |
| 01/14/2009 | EP2014344A2 A method and process for controlling the temperature-, pressure- and density profiles in dense fluid processes |
| 01/14/2009 | EP2014307A2 Micellar drug delivery vehicles and uses thereof |
| 01/14/2009 | EP2014305A1 Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
| 01/14/2009 | EP2014304A1 Colon cleansing compositions |
| 01/14/2009 | EP2014300A1 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene WT1 and a cationic liposome |
| 01/14/2009 | EP2014289A1 Pharmaceutical composition for intracellular acidification with cis-urocanid acid |
| 01/14/2009 | EP2014288A1 Combination of benzyl-4, 5-dihydro-1H-imidazole derivative and an opioid receptor ligand |
| 01/14/2009 | EP2014286A2 Cremophor free epothilone particles coated with protein for treating cancer |
| 01/14/2009 | EP2014280A1 Micro-particles, blood-substitute and method for forming same |
| 01/14/2009 | EP2014279A1 Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| 01/14/2009 | EP2013255A1 Chewing compositions for cosmetic products |
| 01/14/2009 | EP2013237A2 Biopolymer system for tissue sealing |
| 01/14/2009 | EP2013138A1 Method for preparing nano-scale particle of active material |
| 01/14/2009 | EP2013016A2 Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery |
| 01/14/2009 | EP2012937A2 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same |
| 01/14/2009 | EP2012831A2 Nanogel contrast agents for optical molecular imaging |
| 01/14/2009 | EP2012788A2 Pre-mixed, ready-to-use iv bolus compositions and methods of use |
| 01/14/2009 | EP2012768A1 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures |
| 01/14/2009 | EP2012767A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye |
| 01/14/2009 | EP2012757A2 Asymmetric membranes for drug delivery devices |
| 01/14/2009 | EP2012756A2 Multiple unit compositions |
| 01/14/2009 | EP2012755A2 Niosome-hydrogel drug delivery |
| 01/14/2009 | EP2012754A1 Oral rapid release pharmaceutical formulation for pyridylmethylsulfinyl-benzimidazoles |
| 01/14/2009 | EP2012753A2 Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0]hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| 01/14/2009 | EP2012752A2 Use of polymeric materials with other substances for improved performance |
| 01/14/2009 | EP2012751A2 Novel nanoparticles for delivery of active agents |
| 01/14/2009 | EP2012750A2 Methods for coacervation induced liposomal encapsulation and formulations thereof |
| 01/14/2009 | EP2012749A2 Pharmaceutical composition containing a taxane derivative, destined for the preparation of an infusion solution, method of preparation thereof and use thereof |
| 01/14/2009 | EP2012748A2 Device for the controlled release of a substance and method of releasing a substance |
| 01/14/2009 | EP2012747A1 Polymeric masticatory masses for cosmetic products |
| 01/14/2009 | EP2012746A2 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue |
| 01/14/2009 | EP2012706A2 Pharmaceutical formulations for iontophoretic methotrexate delivery |
| 01/14/2009 | EP2012705A2 Pharmaceutical formulations for iontophoretic drug delivery |
| 01/14/2009 | EP1922060B1 Intravenous propofol emulsion compositions having preservative efficacy |
| 01/14/2009 | EP1919446A4 Method for treating skin irritations such as diaper rash and the like |
| 01/14/2009 | EP1811956A4 Method of reducing nosocomial infections |
| 01/14/2009 | EP1651221B1 Medicaments for inhalation comprising betamimetics and an anticholinergic agent |
| 01/14/2009 | EP1646365B1 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 01/14/2009 | EP1635894A4 Medication infusion device using negatively biased ambient pressure medication chamber |
| 01/14/2009 | EP1602404B1 Medicament in fine particle form, method and device for preparation thereof, and agent for parenteral injection and method for production thereof |
| 01/14/2009 | EP1601816A4 Dual electrode advanced electrochemical delivery system |
| 01/14/2009 | EP1601350B1 Titration dosing regimen for controlled release tramadol |
| 01/14/2009 | EP1592402A4 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 01/14/2009 | EP1588707B1 Stable solid medicinal composition for oral administration of ramosetron |
| 01/14/2009 | EP1567164B1 Use of loxapine for the manufacture of a medicament for the treatment of pain |
| 01/14/2009 | EP1567125B1 Pharmaceutical compositions suitable for the treatment of ophthalmic diseases |
| 01/14/2009 | EP1536843A4 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 01/14/2009 | EP1487486B1 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 01/14/2009 | EP1480602B1 Method for producing emulsions |
| 01/14/2009 | EP1478351B1 Rapidly soluble film covering based on polyvinylalcohol-polyether graft copolymers combined with polyvinylalcohol |
| 01/14/2009 | EP1439871B1 Microneedle transport device |
| 01/14/2009 | EP1438029A4 Method and system for non-vascular sensor implantation |
| 01/14/2009 | EP1429915B1 Systems, methods and apparatuses for manufacturing dosage forms |
| 01/14/2009 | EP1429769B1 New formulations and use thereof |
| 01/14/2009 | EP1406678B1 Drug delivery matrices to enhance wound healing |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP1348428B1 Powdery preparations and process for producing the same |
| 01/14/2009 | EP1311241B1 Use of a porous carrier |
| 01/14/2009 | EP1245636B1 Composition for hydrogel, hydrogel, and use thereof |
| 01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/14/2009 | EP1223978B1 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | EP1051189B2 Vaccine formulation containing a polycation as an adjuvant and sugar-alcohols and low concentrations of anorganic ions |
| 01/14/2009 | CN201180187Y Structure of medical dressing producing machine |
| 01/14/2009 | CN201179205Y Diclofenac sodium dual-release capsule tablet |
| 01/14/2009 | CN201179204Y Bullough pseudoephedrine sustained-release capsules |
| 01/14/2009 | CN201179203Y Naproxen sodium pseudoephedrine dual-release capsule |
| 01/14/2009 | CN101346443A Coating agent |
| 01/14/2009 | CN101346393A Modified siRNA molecules and uses thereof |
| 01/14/2009 | CN101346154A Water-soluble films comprising low-viscosity alginates |
| 01/14/2009 | CN101346148A Nanoparticles of a heterocrystal mineral for use as a medicament and method of producing the same |
| 01/14/2009 | CN101346139A Long term weight maintenance |
| 01/14/2009 | CN101346135A PH modulated films for delivery of actives |
| 01/14/2009 | CN101346134A Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers |
| 01/14/2009 | CN101346133A Masking the taste of powders |
| 01/14/2009 | CN101346132A Crystalline pyrimidine nucleoside derivatives suspensions in capsules |
| 01/14/2009 | CN101346131A Protein-based delivery system for overcoming resistance in tumour cells |
| 01/14/2009 | CN101346130A Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
| 01/14/2009 | CN101346129A Method for producing vitamin E-adsorbates |
| 01/14/2009 | CN101346128A Formulation comprising a drug of low water solubility and method of use thereof |
| 01/14/2009 | CN101346127A A delivery system |
| 01/14/2009 | CN101343652A Mushroom ferment crude protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343651A Mushroom ferment pure protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343624A Recombined human growth hormone gene bacilliform virus, preparation and application thereof |
| 01/14/2009 | CN101343330A Preparation method for panax ginseng polyoses extract |
| 01/14/2009 | CN101343320A Anti-vibrio parahaemolyticus chicken yolk antibody, preparation method and application thereof |
| 01/14/2009 | CN101342370A Instant jelly glue of carbomer for eyes |
| 01/14/2009 | CN101342369A Safety environment-friendly type medicinal propellant |
| 01/14/2009 | CN101342366A SOD oxidation resistant composition and preparation thereof |
| 01/14/2009 | CN101342363A Preparation of sedative and brain-invigorating oral liquid |